We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Numab Therapeutics AG has announced a research and option agreement with Ono Pharmaceutical Co., Ltd. for the identification of a multi-specific antibody candidate for development in immuno-oncology.